Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year
- Resource Type
- Article
- Source
- In
Vaccine 27 January 2023 41(5):1042-1049 - Subject
- Language
- ISSN
- 0264-410X